Health care stocks were higher late Friday afternoon, with the NYSE Health Care Index up 0.3% and the Health Care Select Sector SPDR Fund (XLV) rising 0.4%.
The iShares Biotechnology ETF (IBB) increased 0.2%.
In corporate news, Sanofi (SNY) is close to finalizing a deal this weekend to sell control of its consumer health unit Opella to Clayton Dubilier & Rice, Bloomberg reported. Sanofi shares added 0.2%.
Bright Minds Biosciences (DRUG) shares soared 159% after the company said Friday that it launched a private placement of shares at $21.70 apiece.
CVS Health (CVS) shares tumbled past 5%. The company said Friday it named David Joyner as its new chief executive, while issuing a preliminary Q3 earnings outlook that came in below analysts' estimates.
Orgenesis (ORGS) shares plunged 35% after the company said in a regulatory filing it was notified that the Nasdaq hearings panel has decided to delist its shares and suspend trading, effective Monday.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。